Provided are oral dosage forms that contain carbinoxamine in an immediate release format and pseudoephedrine in a prolonged release format. The biphasic oral dosage forms may also contain other active ingredients in combination with carbinoxamine including other decongestants antitussives analgesics and expectorants.

PURPOSE: A pharmaceutical composition is provided to enhance the interaction of drugs using a medicinal herb extract and pseudoephedrine, thereby increasing an effect of treating allergic rhinitis and to reduce side effects of the drugs and the frequency of administration. CONSTITUTION: A sustained release pharmaceutical composition for preventing or treating allergic rhinitis contains pseudoephedrine

ABSTRACT - 600243 The disclosure relates to an agent consisting of theobromine and a decongestant as a combined preparation for use in a therapy of cough wherein the agent is manufactured for administration by an oral route wherein the decongestant is selected from ephedrine levmetamfetamine naphazoline oxymetazoline phenylephrine phenylpropanolamine propylhexedrine pseudoephedrine synephrine and tetrahydrozoline and wherein the decongestant preferably pseudoephedrine is to be administered in a ...

There is provided a modified release liquid pharmaceutical composition comprising combination of dextromethorphan, bromrpheniramine and pseudoephedrine or pharmaceutically acceptable salts thereof. The invention further provides process for preparation of such compositions.

Provided are oral dosage forms that contain carbinoxamine in an immediate release format and pseudoephedrine in a prolonged release format. The biphasic oral dosage forms may also contain other active ingredients in combination with carbinoxamine including other decongestants antitussives analgesics and expectorants.

A tamper resistant drug delivery system made of at least one lipid, at least one gelling agent and at least one sympathomimetic amine, such as for example pseudoephedrine, wherein the system gels in the presence of water or a solution containing water and ethanol, wherein the sympathomimetic amine releases into the digestive system when ingested, and wherein the weight ratio of gelling agent to lipid is less than 1:1.4.